CBDNewsBreaks – ChineseInvestors.com Inc.’s (CIIX) CBD Biotech Subsidiary Drives Company Growth

January 23, 2020 15:01:16

ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang recently discussed the company’s growth potential and the vital role of its CBD Biotech subsidiary during an interview on MoneyTV with Donald Baillargeon (http://cnw.fm/6imjU). An article discussing the company reads, “[Wang] cited the high gross margins of CBD cosmetics for the company and said the firm would work to bring more of that profitability down to the bottom line through lower costs and restructuring. CIIX offers a variety of products in its line, ranging from hemp wine to CBD-infused cosmetics. . . . ‘We can achieve in cosmetic products a 10X to 20X profit margin. That’s quite a big profit,’ Wang said in the interview. ‘Our goal is to make the company healthier by stabilizing it and making it not as reliant on the street for financing.’”

To view the full article, visit http://cnw.fm/KGrS5

About ChineseInvestors.com Inc.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.